| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Common Stock | Sale | -$155K | -2.32K | -1.05% | $66.53 | 219K | Apr 1, 2024 | Direct | F1, F2 |
| transaction | PCVX | Common Stock | Sale | -$45.5K | -677 | -0.31% | $67.23 | 218K | Apr 1, 2024 | Direct | F1, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023. |
| F2 | The price reported is a weighted-average price. The shares were sold at prices ranging from $66.09 to $67.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The price reported is a weighted-average price. The shares were sold at prices ranging from $67.13 to $68.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |